CLINICAL_TRIALS
ClinicalTrials.gov record update
Pembrolizumab in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02837263
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:07.575254+00:00
- Published At
- 2023-06-12T00:00:00+00:00
- Record Updated At
- 2023-06-12
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Colorectal Cancer", "Colorectal Adenocarcinoma", "Stage IVA Colorectal Cancer", "Stage IVB Colorectal Cancer", "Metastatic Carcinoma in the Liver"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-06-12"- protocolSection.identificationModule.nctId
"NCT02837263"- protocolSection.identificationModule.officialTitle
"Pembrolizumab in Combination With Stereotactic Body Radiotherapy for Liver Metastatic Colorectal Cancer"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.